SCHEMBL25459495

SCHEMBL25459495

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc(-c5cccc(-c6cccc7c6oc6c(-c8ccccc8)cccc67)c5)nc4c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.44
RAB9A P51151 6/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
KDM4E B2RXH2 5/20 0.44
HPGD P15428 4/20 0.44
CASP3 P42574 2/20 0.44
SENP7 Q9BQF6 2/20 0.44
SENP6 Q9GZR1 2/20 0.44
POLB P06746 1/20 0.44
SENP8 Q96LD8 1/20 0.44
HPSE Q9Y251 3/20 0.44
MAPT P10636 4/20 0.43
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HDAC6 Q9UBN7 4/20 0.41
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21891142 0.95 HPSE (0.47) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL23473802 0.94 SMN1; SMN2 (0.48) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL25459423 0.93 TP53 (0.44) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL25459493 0.93 ALOX5 (0.48) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL23473825 0.92 SMN1; SMN2 (0.46) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL25459694 0.91 VSIR (0.45) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL25459422 0.90 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL23473644 0.90 NPC1 (0.49) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL23473784 0.89 SMN1; SMN2 (0.45) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL25459600 0.87 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX NPC1 1470/4885RAB9A 3117/4885SMN1; SMN2 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.